ABIGAIL TUNON: Open Payments
NPI 1811423825 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,956 in 159 payments from 17 companies in 2025. Trend: 2023 $467 · 2024 $2,176 · 2025 $3,956
Food & beverage: $3,956
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $990 |
| Madrigal Pharmaceuticals | 22 | $919 |
| Janssen Biotech, Inc. | 18 | $667 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $278 |
| Regeneron Healthcare Solutions, Inc. | 8 | $199 |
| QOL Medical, LLC | 6 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $156 |
| Ardelyx, Inc. | 7 | $143 |
| Phathom Pharmaceuticals, Inc. | 17 | $132 |
| GENZYME CORPORATION | 3 | $76 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, XIFAXAN, Sucraid, ENTYVIO.
Industry payments across AL — which companies pay providers there.
